Midsayap Diagnostic Center and Hospital

Global Drug Delivery Devices Market Report 2022: Featuring Key Players F. Hoffmann-La Roche, 3M Company, Pfizer & Baxter International - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 20, 2022
Pharmaceutical, Health, Medical Devices, WHO, Midsayap Diagnostic Center and Hospital, Diabetes, Asia-Pacific, MDSAP, World Health Organization, Conditional sentence, Moyamoya disease, Cancer, Hospital, IHD, Drug delivery, Ophthalmic drug administration, Degenerative disease, Route of administration, Stroke, Death, Lists of countries and territories, Health care, Growth, Administration, Prevalence, Medical device, Pharmaceutical industry

The "Global Drug Delivery Devices Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Drug Delivery Devices Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • Asia Pacific was the second-largest region in the drug delivery devices market.
  • The regulatory changes related to medical devices is expected to restraint the growth of drug delivery devices market.
  • 1) By Route Of Administration: Oral Drug Delivery; Injectable Drug Delivery; Topical Drug Delivery; Ocular Drug Delivery; Pulmonary Drug Delivery; Nasal Drug Delivery; Transmucosal Drug Delivery; Implantable Drug Delivery
    2) By Patient Care Setting: Hospitals; Diagnostic Centers; Ambulatory Surgery Centers/Clinics; Home Care Settings; Other Patient Care Settings

Autoimmune Disease Diagnostics Market to hit USD 2 billion by 2030, says Global Market Insights Inc.

Retrieved on: 
Wednesday, July 13, 2022
Technology, Prevalence, MicroRNA, Infection, CRP, NCBI, Abbott Laboratories, Gene expression, Autoimmune disease, Biotechnology, Incidence, Midsayap Diagnostic Center and Hospital, Leukemia, CBC, C-reactive protein, SLE, Anemia, Awareness, Degenerative disease, Patient satisfaction, Renewable energy, Patient, Diagnosis, Thermo Fisher Scientific, Lupus, Cell, Bio-Rad Laboratories, Hospital, Psoriasis, Research report, CAGR, Woman, Research, Adoption, Growth, Industry, Complete blood count, CDC, USD, Vaccine, Fine chemical, Clinical urine tests

SELBYVILLE, Del., July 13, 2022 /PRNewswire/ -- The autoimmune disease diagnostics market value is expected to surpass USD 2 billion by 2030, according to a new research report by Global Market Insights Inc.

Key Points: 
  • Systemic autoimmune disease segment is set to cross USD 618 million by 2030.
  • Some major findings of the autoimmune disease diagnostics market report include:
    Growing prevalence of autoimmune diseases will drive the market size.
  • China autoimmune disease diagnostics market is likely to witness 8.5% CAGR from 2022 to 2030.
  • Supportive government policies and increasing awareness regarding autoimmune disease diagnostics among people in China will augment the market outlook.

Smart Drugs & Pills Global Market Report 2022-2027: Increased Preference for Less Complex and Painful Diagnostic Examinations with Minimally Invasive Surgeries Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, July 4, 2022
Health, Pharmaceutical, USD, Research, COVID-19, Capsule endoscopy, Monitoring, Tisbury Great Pond Target Area, Smart drug, CAGR, Stomach, Midsayap Diagnostic Center and Hospital, Compound annual growth rate, Esophagus, Drug, Hospital, Application

The Global Smart Drugs & Pills Market size was estimated at USD 4,262.38 million in 2021, USD 5,124.99 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 20.41% to reach USD 12,993.72 million by 2027.

Key Points: 
  • The Global Smart Drugs & Pills Market size was estimated at USD 4,262.38 million in 2021, USD 5,124.99 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 20.41% to reach USD 12,993.72 million by 2027.
  • This research report categorizes the Smart Drugs & Pills to forecast the revenues and analyze the trends in each of the following sub-markets:
    Based on Target Area, the market was studied across Esophagus, Large Intestine, Small Intestine, and Stomach.
  • Based on End User, the market was studied across Diagnostic Centers, Hospitals, and Research Institutes.
  • This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Smart Drugs & Pills market considering the current update on the conflict and its global response.

The Worldwide Artificial Intelligence In Medical Imaging Industry is Expected to Reach $3.2 Billion by 2027 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 1, 2022
Technology, Radiology, Health, Artificial Intelligence, Acquisition, Decision-making, USD, Strategic management, Market share analysis, Hospital, Value, R, Business Growth Fund, COVID-19, Customer support, Growth, Investment, Certification, CAGR, Midsayap Diagnostic Center and Hospital, Use, Artificial intelligence, Compound annual growth rate, Medical device, Retail

Which are the products/segments/applications/areas to invest in over the forecast period in the Global Artificial Intelligence In Medical Imaging Market?

Key Points: 
  • Which are the products/segments/applications/areas to invest in over the forecast period in the Global Artificial Intelligence In Medical Imaging Market?
  • What are the technology trends and regulatory frameworks in the Global Artificial Intelligence In Medical Imaging Market?
  • What is the market share of the leading vendors in the Global Artificial Intelligence In Medical Imaging Market?
  • What modes and strategic moves are considered suitable for entering the Global Artificial Intelligence In Medical Imaging Market?

United States Smart Drugs & Pills Market Research Report 2022: Featuring Key Players Boston Scientific Corporation, GE Healthcare, Olympus Corporation & Others - ResearchAndMarkets.com

Retrieved on: 
Friday, June 24, 2022
Pharmaceutical, Alternative Medicine, General Health, Health, Medical Devices, Hospitals, Vitamins, Supplements, Fitness & Nutrition, Acquisition, Decision-making, USD, Research, Strategic management, Market share analysis, Value, Mergers and acquisitions, Business Growth Fund, Customer support, COVID-19, Growth, Capsule endoscopy, Collaborative partnership, Monitoring, Smart drug, Tisbury Great Pond Target Area, Investment, CAGR, Weakness, Stomach, Use, News, Midsayap Diagnostic Center and Hospital, Compound annual growth rate, State, Esophagus, Gaps, Retail, Hospital, Application

The "Smart Drugs & Pills Market Research Report by Target Area (Esophagus, Large Intestine, and Small Intestine), End User, Application, State - United States Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Smart Drugs & Pills Market Research Report by Target Area (Esophagus, Large Intestine, and Small Intestine), End User, Application, State - United States Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
  • This research report categorizes the Smart Drugs & Pills to forecast the revenues and analyze the trends in each of the following sub-markets:
    Based on Target Area, the market was studied across Esophagus, Large Intestine, Small Intestine, and Stomach.
  • Based on End User, the market was studied across Diagnostic Centers, Hospitals, and Research Institutes.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Global 3D Cardiac Mapping Market (2022 to 2027) - Focus on Launch of Innovative Products Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Monday, June 20, 2022
Radiology, Health Technology, Health, Cardiology, CAGR, Industry, Ansoff Matrix, Observation, Competitive analysis, Clifton Springs Hospital & Clinic, COVID-19, Growth, USD, Emotion, Investment, Midsayap Diagnostic Center and Hospital, Market development, SWOT, Geography, Impact, Porter's five forces analysis, Hospital, Risk, Medical device, Marketing, Risk management, Retail, Technology

Market dynamics are forces that impact the prices and behaviors of the Global 3D Cardiac Mapping Market stakeholders.

Key Points: 
  • Market dynamics are forces that impact the prices and behaviors of the Global 3D Cardiac Mapping Market stakeholders.
  • The report presents a detailed Ansoff matrix analysis for the Global 3D Cardiac Mapping Market.
  • The report analyses the Global 3D Cardiac Mapping Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • The report offers a comprehensive evaluation of the Global 3D Cardiac Mapping Market.

Global Brain Monitoring Devices Market Size Will Reach USD 9.86 Billion By 2030, at CAGR of 6.6%: Polaris Market Research

Retrieved on: 
Wednesday, May 25, 2022
Dementia, Parkinson's disease, ICP, List of Hindawi academic journals, Brain damage, Population, Midsayap Diagnostic Center and Hospital, Conditional sentence, Electroencephalography, Intracranial pressure, Disease, CT, Magnetic resonance imaging, Magnetoencephalography, MRI, TCD, PET, Geography, Lists of diseases, Electromyography, Headache, Stroke, Research, EMG, Industry, EEG, Huntington's disease, Detail, MEG, Prevalence, Application, National Competitiveness Report of Armenia, Growth, Online shopping, Medical imaging, Hospital, Epilepsy

Among these electroencephalography (EEG) equipment segment is anticipated to lead the global monitoring equipment market.

Key Points: 
  • Among these electroencephalography (EEG) equipment segment is anticipated to lead the global monitoring equipment market.
  • Based on application, the market is categorized into dementia, Epilepsy, Parkinson's Disease, Headache Disorders, Huntington's Disease, Traumatic Brain Injuries, Stroke, Sleep Disorders, and Others.
  • The traumatic brain injuries application segment is expected to account for the largest market share over the forecast period.
  • What factors make the brain monitoring devices market a good long-term investment?

Intrivo donates over $1M in COVID-19 tests, as well as computers and software, to war-torn Ukrainian hospitals in-need

Retrieved on: 
Wednesday, May 25, 2022
Hospital, Software, Computer, IOS, Population, Public health, Infection, AI, Non-governmental organization, Patient, Solution, Nursing, COVID-19, User-centered design, JDC, Vaccination, Android, FDA, Midsayap Diagnostic Center and Hospital, Good, Technology, Organization, Go A, Medical Center, Refugee, Prevalence, American Jewish Joint Distribution Committee, Pharmaceutical industry, Health

MIAMI, May 25, 2022 /PRNewswire/ -- Intrivo, a leading U.S.-based health technology company, announced today a recent donation of more than $1 million USD worth of their popular On/Go™ COVID-19 tests, along with accompanying population health management software and hardware, to hospitals across Ukraine who have been deeply impacted by the recent war. With the conflict entering its fourth month, and the surge in COVID-19 cases in many places around the world, including Europe, the top-rated On/Go COVID-19 rapid tests are helping Ukraine keep its health system functional in a time of strife and immense need.

Key Points: 
  • Kharkiv hospital was bombed out," recounted Dr. Orest Tril, Deputy General Director and Head Physician at the Lviv Oncological Regional Medical and Diagnostic Center.
  • Intrivo co-CEO Ron Gutman personally accompanied the On/Go tests, computers, and software to Ukraine last week, on a mission coordinated with leading NGOs and Intrivo's local Ukrainian engineers.
  • And even more so, to predict and prevent a new COVID-19 surge in the absence of publicly-available resources to handle it effectively."
  • Dr. Andrii Syniuta, Director of the Western Ukrainian Specialized Children's Medical Center, further explained that, "These [premature] children need more support with medications, facilities and equipment".

Microbiology Testing/Clinical Microbiology Market size worth $ 10.11 Billion, Globally, by 2028 at 10.17% CAGR: Verified Market Research®

Retrieved on: 
Monday, April 11, 2022
Market research, Company, CAGR, DST, USD, World Health Organization, Agilent Technologies, Diagnosis, Microbiology, Coronavirus, Mortality, Research, Epidemic, World, Incidence, Midsayap Diagnostic Center and Hospital, Prevalence, Roche, Abbott, Department of Science and Technology, Diarrhea, Government, Health, COVID-19, Becton, Dickinson and Company headquarters, Thermo Fisher Scientific, Geography, Urinary tract infection, Solution, Department, Tuberculosis, Degenerative disease, Bloodstream infections, Hospital, Infection, Pharmaceutical industry, Medical device, Bruker, Technology

JERSEY CITY, N.J., April 11, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Microbiology Testing/Clinical Microbiology Market" By Product (Instruments, Reagents), By Disease Area (Respiratory Diseases, Bloodstream Infections), By Application (Pharmaceutical Applications, Energy Applications), By End User (Hospitals and Diagnostic Centers, Academic and Research Institutes), and By Geography. According to Verified Market Research, the Global Microbiology Testing/Clinical Microbiology Market size was valued at USD 4.66 Billion in 2020 and is projected to reach USD 10.11 Billion by 2028, growing at a CAGR of 10.17% from 2021 to 2028.

Key Points: 
  • Technological developments in disease diagnostics, growing incidence of infectious diseases, increased public-private investments & funding, and rise in outbreaks of epidemics have been driving the Microbiology Testing/Clinical Microbiology Market.
  • According to Verified Market Research, the Global Microbiology Testing/Clinical Microbiology Market size was valued at USD 4.66 Billion in 2020 and is projected to reach USD 10.11 Billion by 2028, growing at a CAGR of 10.17% from 2021 to 2028.
  • As a result of the rising prevalence and incidence of infectious diseases, the demand for microbiological testing is increasing, leading to global market growth.
  • Verified Market Research has segmented the Global Microbiology Testing/Clinical Microbiology Market On the basis of Product, Disease Area, Application, End User, and Geography.

Microbiology Testing/Clinical Microbiology Market size worth $ 10.11 Billion, Globally, by 2028 at 10.17% CAGR: Verified Market Research®

Retrieved on: 
Monday, April 11, 2022
Market research, Company, CAGR, DST, USD, World Health Organization, Agilent Technologies, Diagnosis, Microbiology, Coronavirus, Mortality, Research, Epidemic, World, Incidence, Midsayap Diagnostic Center and Hospital, Prevalence, Roche, Abbott, Department of Science and Technology, Diarrhea, Government, Health, COVID-19, Becton, Dickinson and Company headquarters, Thermo Fisher Scientific, Geography, Urinary tract infection, Solution, Department, Tuberculosis, Degenerative disease, Bloodstream infections, Hospital, Infection, Pharmaceutical industry, Medical device, Bruker, Technology

JERSEY CITY, N.J., April 11, 2022 /PRNewswire/ -- Verified Market Research recently published a report, "Microbiology Testing/Clinical Microbiology Market" By Product (Instruments, Reagents), By Disease Area (Respiratory Diseases, Bloodstream Infections), By Application (Pharmaceutical Applications, Energy Applications), By End User (Hospitals and Diagnostic Centers, Academic and Research Institutes), and By Geography. According to Verified Market Research, the Global Microbiology Testing/Clinical Microbiology Market size was valued at USD 4.66 Billion in 2020 and is projected to reach USD 10.11 Billion by 2028, growing at a CAGR of 10.17% from 2021 to 2028.

Key Points: 
  • Technological developments in disease diagnostics, growing incidence of infectious diseases, increased public-private investments & funding, and rise in outbreaks of epidemics have been driving the Microbiology Testing/Clinical Microbiology Market.
  • According to Verified Market Research, the Global Microbiology Testing/Clinical Microbiology Market size was valued at USD 4.66 Billion in 2020 and is projected to reach USD 10.11 Billion by 2028, growing at a CAGR of 10.17% from 2021 to 2028.
  • As a result of the rising prevalence and incidence of infectious diseases, the demand for microbiological testing is increasing, leading to global market growth.
  • Verified Market Research has segmented the Global Microbiology Testing/Clinical Microbiology Market On the basis of Product, Disease Area, Application, End User, and Geography.